Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2019, Article ID 9179308, 7 pages
https://doi.org/10.1155/2019/9179308
Research Article

Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14

School of Basic Medical Science, North Sichuan Medical College, Nanchong 637000, China

Correspondence should be addressed to Jian Yang; moc.361@47ynaij

Received 19 August 2018; Revised 5 December 2018; Accepted 10 January 2019; Published 3 March 2019

Academic Editor: Maria Lina Tornesello

Copyright © 2019 Rong Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Chambers, C. S. Hahn, R. Galler, and C. M. Rice, “Flavivirus genome organization, expression, and replication,” Annual Review of Microbiology, vol. 44, no. 1, pp. 649–688, 1990. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Turtle, A. Jung, N. J. Beeching et al., “An integrated model of care for neurological infections: the first six years of referrals to a specialist service at a university teaching hospital in Northwest England,” BMC Infectious Diseases, vol. 15, no. 1, p. 387, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Thongtan, P. Cheepsunthorn, V. Chaiworakul, C. Rattanarungsan, N. Wikan, and D. R. Smith, “Highly permissive infection of microglial cells by Japanese encephalitis virus: a possible role as a viral reservoir,” Microbes and Infection, vol. 12, no. 1, pp. 37–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Wang, S. H. Li, L. Zhu et al., “Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability,” Nature Communications, vol. 8, no. 1, p. 14, 2017. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Villordo and A. V. Gamarnik, “Genome cyclization as strategy for flavivirus RNA replication,” Virus Research, vol. 139, no. 2, pp. 230–239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. B. D. Lindenbach and C. M. Rice, “Molecular biology of flaviviruses,” Advances in Virus Research, vol. 59, pp. 23–61, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. S. B. Halstead and S. J. Thomas, “New Japanese encephalitis vaccines: alternatives to production in mouse brain,” Expert Review of Vaccines, vol. 10, no. 3, pp. 355–364, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. K. L. Dubischar, V. Kadlecek, B. Sablan Jr. et al., “Safety of the inactivated Japanese encephalitis virus vaccine IXIARO in children,” Pediatric Infectious Disease Journal, vol. 36, no. 9, pp. 889–897, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. K. L. Dubischar, V. Kadlecek, B. Sablan et al., “Immunogenicity of the inactivated Japanese encephalitis virus vaccine IXIARO in children from a Japanese encephalitis virus-endemic region,” Pediatric Infectious Disease Journal, vol. 36, no. 9, pp. 898–904, 2017. View at Publisher · View at Google Scholar · View at Scopus
  10. M. B. Appaiahgari and S. Vrati, “Clinical development of IMOJEV-a recombinant Japanese encephalitis chimeric vaccine (JE-CV),” Expert Opinion on Biological Therapy, vol. 12, no. 9, pp. 1251–1263, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. D. W. Trent, P. Minor, T. Jivapaisarnpong, and J. Shin, “WHO working group on the quality, safety and efficacy of Japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21–23 February 2012,” Biologicals, vol. 41, no. 6, pp. 450–457, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Yu, “Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities,” Vaccine, vol. 28, no. 21, pp. 3635–3641, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Kumar, P. Tripathi, and A. Rizvi, “Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis,” New England Journal of Medicine, vol. 360, no. 14, pp. 1465-1466, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. B. Bista, M. Banerjee, S. H. Shin et al., “Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study,” The Lancet, vol. 358, no. 9284, pp. 791–795, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Ohrr, J. Tandan, Y. M. Sohn, S. H. Shin, D. P. Pradhan, and S. B. Halstead, “Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study,” The Lancet, vol. 366, no. 9494, pp. 1375–1378, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Nitayaphan, J. A. Grant, G.-J. J. Chang, and D. W. Trent, “Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2,” Virology, vol. 177, no. 2, pp. 541–552, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Ni, N. J. Burns, G.-J. J. Chang et al., “Comparison of nucleotide and deduced amino acid sequence of the 5 non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives,” Journal of General Virology, vol. 75, no. 6, pp. 1505–1510, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Ni, G.-J. J. Chang, H. Xie, D. W. Trent, and A. D. T. Barrett, “Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14,” Journal of General Virology, vol. 76, no. 2, pp. 409–413, 1995. View at Publisher · View at Google Scholar
  19. Y. Zhou, R. Wu, Q. Zhao et al., “Mutation of I176R in the E coding region weakens Japanese encephalitis virus neurovirulence, but not its growth rate in BHK-21 cells,” Archives of virology, vol. 163, no. 5, pp. 1351–1355, 2018. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Yang, H. Yang, Z. Li et al., “Envelope protein mutations L107F and E138K are important for neurovirulence attenuation for Japanese encephalitis virus SA14-14-2 strain,” Viruses, vol. 9, no. 1, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. S. I. Yun, B. H. Song, J. K. Kim et al., “A molecularly cloned, live-attenuated Japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in mice,” PLoS Pathogens, vol. 10, no. 7, Article ID e1004290, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. G. D. Gromowski, C.-Y. Firestone, and S. S. Whitehead, “Genetic determinants of Japanese encephalitis virus vaccine strain SA14-14-2 that Govern attenuation of virulence in mice,” Journal of Virology, vol. 89, no. 12, pp. 6328–6337, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Zhao, T. Date, Y. Li et al., “Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone,” Journal of General Virology, vol. 86, no. 8, pp. 2209–2220, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. T. J. Chambers, D. A. Droll, X. Jiang, W. S. M. Wold, and J. A. Nickells, “JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease,” Virology, vol. 366, no. 1, pp. 51–61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. T. J. Chambers, X. Jiang, D. A. Droll, Y. Liang, W. S. M. Wold, and J. Nickells, “Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice,” Journal of General Virology, vol. 87, no. 11, pp. 3131–3140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S.-I. Yun, S.-Y. Kim, C. M. Rice, and Y.-M. Lee, “Development and application of a reverse genetics system for Japanese encephalitis virus,” Journal of virology, vol. 77, no. 11, pp. 6450–6465, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Racaniello and D. Baltimore, “Cloned poliovirus complementary DNA is infectious in mammalian cells,” Science, vol. 214, no. 4523, pp. 916–919, 1981. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Schlesinger and T. W. Dubensky, “Alphavirus vectors for gene expression and vaccines,” Current Opinion in Biotechnology, vol. 10, no. 5, pp. 434–439, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Sumiyoshi, C. H. Hoke, and D. W. Trent, “Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates,” Journal of Virology, vol. 66, no. 9, pp. 5425–31, 1992. View at Google Scholar
  30. F. Zhang, Q. Huang, W. Ma, S. Jiang, Y. Fan, and H. Zhang, “Amplification and cloning of the full-length genome of Japanese encephalitis virus by a novel long RT-PCR protocol in a cosmid vector,” Journal of Virological Methods, vol. 96, no. 2, pp. 171–182, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. C.-J. Lai and T. P. Monath, “Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis,” Advances in Virus Research, vol. 61, pp. 469–509, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Monath, K. Soike, I. Levenbook et al., “Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates,” Vaccine, vol. 17, no. 15-16, pp. 1869–1882, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. T. R. Bhatt, B. R. Miller, M. B. Crabtree, F. Guirakhoo, and T. P. Monath, “Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF/JE SA14--14--2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes,” American Journal of Tropical Medicine and Hygiene, vol. 62, no. 4, pp. 480–484, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. T. P. Monath, I. Levenbook, K. Soike et al., “Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys,” Journal of Virology, vol. 74, no. 4, pp. 1742–1751, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Yang, H. Yang, Z. Li et al., “The chimeric Japanese encephalitis/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus,” Protein & Cell, vol. 8, no. 3, pp. 225–229, 2017. View at Publisher · View at Google Scholar · View at Scopus